Cargando…
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
SIMPLE SUMMARY: Metastatic colorectal cancer is common and complicated to treat. The first choice of treatment is guided by the genetics of the patients (RAS mutation status) and the location of their primary tumor. However, real-world information on what treatments are actually being used and the s...
Autores principales: | Pericay, Carles, Fernández Montes, Ana, Alonso Orduña, Vicente, Macias Declara, Ismael, Asensio Martínez, Elena, Rodríguez Salas, Nuria, Torres, Esperanza, Cacho Lavín, Diego, Rodríguez Alonso, Rosa María, Falcó, Esther, Oliva, Joan Carles, Cirera, Lluis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526223/ https://www.ncbi.nlm.nih.gov/pubmed/37760572 http://dx.doi.org/10.3390/cancers15184603 |
Ejemplares similares
-
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer
por: Fernández Montes, Ana, et al.
Publicado: (2023) -
In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions
por: Baré, Marisa, et al.
Publicado: (2009) -
RWD-derived response in multiple myeloma
por: Xu, Tao, et al.
Publicado: (2023) -
RWD144 The Short Run and Long Run Behavioral Effects of COVID-19 Vaccination Enforcement
por: Baser, I., et al.
Publicado: (2023) -
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
por: Fernandez-Plana, Julen, et al.
Publicado: (2014)